Application of MR-ProADM to predict prevention of hospitalisation, derived from a multi-centre study
- PMID: 30995933
- PMCID: PMC6472015
- DOI: 10.1186/s13054-019-2402-0
Application of MR-ProADM to predict prevention of hospitalisation, derived from a multi-centre study
Conflict of interest statement
Ethics approval and consent to participate
The original study was approved by the Newcastle and North Tyneside Research Ethics Committee (15/NE/0120), and by the R&D Committee of the Newcastle upon Tyne Hospitals NHS Foundation Trust (reference no. 7495).
Consent for publication
Consent was obtained for the original study.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Comment on
-
The early identification of disease progression in patients with suspected infection presenting to the emergency department: a multi-centre derivation and validation study.Crit Care. 2019 Feb 8;23(1):40. doi: 10.1186/s13054-019-2329-5. Crit Care. 2019. PMID: 30736862 Free PMC article.
References
-
- Saeed K, Wilson DC, Bloos F, Scheutz P, van der Does Y, Melander O, Hausfater P, et al. The early identification of disease progression in patients with suspected infection presenting to the emergency department: a multi-centre derivation and validation study. Crit Care. 2019;23:40. doi: 10.1186/s13054-019-2329-5. - DOI - PMC - PubMed
-
- Graziadio S, O’Leary RA, Stocken DD, Power M, Allen AJ, Simpson AJ, Price DA. Can mid-regional pro-adrenomedullin (MR-proADM) increase the prognostic accuracy of NEWS in predicting deterioration in patients admitted to hospital with mild to moderately severe illness? A prospective single-centre observational study. BMJ Open. 2018;8:e020337. doi: 10.1136/bmjopen-2017-020337. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
